Instinctif HLS

We are the Healthcare & Life Sciences practice of @InstinctifPtnrs

[Instinctif HLS @Instinctif_HLS]

Today, @EpiEndoPharma announced the successful completion of its Phase 2A #ClinicalTrial for #EP395 in patients diagnosed with Chronic Obstructive Pulmonary Disease (#COPD).
https://t.co/hVG2q7MAgg

[Instinctif HLS @Instinctif_HLS]

The latest edition of our Instinctif Healthcare & Life Sciences financial and events calendar is out now - get in touch if you don't already receive a copy and would like to! #healthcare #lifesciences #events

[Instinctif HLS @Instinctif_HLS]

Today, @SkinBioT (AIM: SBTX) announced that its #acquisition, Dermatonics, is launching its Once Heal Balm – used to treat dry foot skin – across Asia, Middle East and Africaregion, with its manufacturing & distribution partner, the Umesh Modi Group #skincare

[Instinctif HLS @Instinctif_HLS]

This morning, @EpiEndoPharma has announced the appointments of Professor Bartolome Celli and Professor Fernando J. Martinez to its Scientific Advisory Board. https://t.co/7nCayA4WVc

[Instinctif HLS @Instinctif_HLS]

Congratulations to @SkinBioT (AIM: SBTX) who announced its first #acquisition in the skincare / woundcare space of Dermatonics this morning.

See announcement here: https://t.co/M05mIjgmQd

[Instinctif HLS @Instinctif_HLS]

This morning, #VectorY has announced the appointment of Khurem Farooq (CEO and Co-Founder of #Aiolos Bio) to its Board of Directors. https://t.co/pen2o368N7

[Instinctif HLS @Instinctif_HLS]

I just love the idea of PhD students providing a summary of their work through the medium of dance. Absolutely inspired and demonstrates the level of creativity required to be a scientist. Fantastic.

[News from Science @NewsfromScience]

An engaging blend of hand fans, #LordOfTheRings, and #Chemistry won Science’s last #DanceYourPhD competition, and we can’t wait to see who takes the next crown.

The latest edition of the contest, our 16th, is now open to entries: https://t.co/CaxKIHAxui

[Instinctif HLS @Instinctif_HLS]

VectorY Therapeutics raised €129 Million in Series A financing to advance vectorized antibody programs in neurodegenerative diseases
Read more here: https://t.co/ar052YVqdu
#VectorY #EQTLifesciences #Forbion

[Instinctif HLS @Instinctif_HLS]

NorthSea Theapeutics to present ICONA phase 2b data as an oral late-breaker session at the 2023 AASLD Liver Meeting
Read more here: https://t.co/VLGvGp1b3Q
#NASH #aasld

[Instinctif HLS @Instinctif_HLS]

Autifony Therapeutics has announced a global licensing and collaboration agreement with Jazz Pharmaceuticals to discover and develop drug candidates targeting 2 different ion channels associated with neurological disorders #Autifony #Biotechnology

[Autifony Therapeutics @AutifonyLtd]

Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders https://t.co/vcK0j1q08e
#Autifony #biotech #innovation #drugdiscovery

[Instinctif HLS @Instinctif_HLS]

@automata_tech welcomed former lead investor Joe Stringer to its leadership team as Exec Chair and Director of Corporate Development (EMEA) yesterday. See the news below.

[Automata @automata_tech]

Former lead investor, Joe Stringer, joins Automata's leadership team 📢

With his long track record in the health and life sciences sector and commitment to making a tangible difference to society, he's a valuable addition.

Read the press release ➡️ https://t.co/cyRp0k9BGY

[Instinctif HLS @Instinctif_HLS]

EpiEndo Pharma today announced its IND-opening DDI study for EP395 to help expand the range of patients for its future trials.

[EpiEndo Pharmaceuticals @EpiEndoPharma]

We've initiated our new IND-opening study, a drug-drug interaction study for EP395 in healthy volunteers. With results expected in Q1 2024, the data from this study will help ensure as wide a range of patients as possible can be included in future trials #COPD #IND #clinicaltrial

[Oxford BioDynamics @OxBioDynamics]

Movember is a time to highlight men’s health issues, and we’re on a mission to raise awareness about #prostatecancer. As the second most common cancer among men, prostate cancer affects millions every year.

This November, we're not just growing mustaches; we're growing conversations about the importance of regular screenings and #earlydetection. Stay tuned for exciting awareness and fundraising activities throughout the month!

#menshealth #movember #pcsm

[Instinctif HLS @Instinctif_HLS]

Our Head of Healthcare and Life Sciences, @mtoynesewell, featured in the latest episode of Instinctif's podcast ip Talks, as she unveils the keys to deciphering health sector communication for investors.

Listen here: https://t.co/zPiWQXNjrx

#Lifesciences #biotech

[Instinctif HLS @Instinctif_HLS]

Pioneer Group today announces its participation in a £2m financing round in ImmuONE, a company developing a 3D human lung model that can assess the safety of new drugs without the use of animal testing.

Read more here: https://t.co/qzVD6Ec0d7

@PioneerGrp

[Instinctif HLS @Instinctif_HLS]

Avelo, Vivolta, and BLINK win €1.5M Eurostars grant to develop new solution for diagnosing lower respiratory tract infections.

Read more here: https://t.co/aSuPFsd8rP

#RTIs #lifesciences

[Instinctif HLS @Instinctif_HLS]

Neurocentrx Reports Positive Top-line Results from Phase 1 Clinical Study of its Lead Oral Ketamine Capsule Programme

Read more here: https://t.co/n38DORjpTf

#ClinicalTrials #PositiveResults #DepressionResearch

[Instinctif HLS @Instinctif_HLS]

HOOKIPA Pharma announces publication of preclinical data of hepatitis B virus (HBV) therapeutic vaccine developed in collaboration with Gilead Sciences

Read more here: https://t.co/LCRCEXB8I9

#HepatitisB #arenavirus #vaccines

@HookipaPharma @GileadSciences

[Instinctif HLS @Instinctif_HLS]

NorthSea Therapeutics Receives FDA Rare Pediatric Disease Designation for SEFA-6179 for the Treatment of Intestinal Failure-Associated Liver Disease
Read more here: https://t.co/x41FfJm5Fy
#IFALD #NASH

[Instinctif HLS @Instinctif_HLS]

To celebrate Ada Lovelace Day, @PioneerGrp and @IgniteFutures are hosting their sixth annual event to celebrate women in the #STEM fields. Over 380 students in the UK are expected to take part, making it their biggest event so far.
Read more here: https://t.co/Ffx2HTKi6a
#ALD23